The study has been published in Circulation, the journal of the American Heart Association.
Milk and soy protein supplementation resulted in lower systolic blood pressure compared to refined-carbohydrate supplementation, according to a recent study published in Circulation, the journal of the American Heart Association.
In the randomized, double-blind crossover study on 352 adults, subjects were given either 40 g/day of soy protein, milk protein, or a carbohydrate supplement, for eight weeks. Compared with the carbohydrate group, the soy protein and milk protein groups showed significantly decreased systolic blood pressure levels of 2.0 mm Hg and 2.3 mm Hg, respectively. The researchers add that diastolic blood pressure was also reduced, although not significantly.
The researchers stated, “…these findings suggest that partially replacing carbohydrate with soy or milk protein might be an important component of nutrition intervention strategies for the prevention and treatment of hypertension.”
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.